However, the assertion that brain insulin resistance is a salient feature of aging, T2D and dementias require a careful evaluation of whether brain insulin resistance is identical at the molecular and physiological level to insulin resistance as traditionally defined in peripheral tissues. This evidence concerns the gene INS and dementia.